Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: Influence of the diagnostic criteria used

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 9, 2012, Pages 1007-1011

  Caballería, Llorenç ^a,b   Pera, Guillem ^b   Rodríguez, Lluís ^b   Auladell, Maria Antònia ^a,b   Bernad, Jesús ^a   Canut, Santiago ^a   Torán, Pere ^a,b  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b Primary Healthcare Research Support Unit Metropolitana Nord   (Spain)

Author keywords

arterial hypertension; cholesterol; diabetes; obesity; triglycerides; ultrasonography

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPAIN; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK; SPAIN; YOUNG ADULT;

EID: 84864875906     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328355b87f     Document Type: Article

References (21)

1. Ludwig J, Viggiano TR, McGuill DB, Oh B.J. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proc 1980; 55:434-438. (Pubitemid 10057164)
2. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implication. Hepatology 2010; 51:679-689.
3. Lazo M, Clark J.M. The epidemiology of non-alcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008; 28:339-350.
4. Everhart JE, Bemba K.M. Fatty liver: think globally. Hepatology 2010; 51:1491-1493.
5. Caballerý́a L, Pera G, Auladell MA, Torán P, Muñ oz L, Miranda D, et al. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur J Gastroenterol Hepatol 2010; 22:24-32.
6. Rector RS, Thyfault JP, Wei Y, Ibdah J.A. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 2008; 14:185-192. (Pubitemid 351314297)
7. Eckel RH, Grundy SM, Zimmet P.Z. The metabolic syndrome. Lancet 2005; 365:1415-1428. (Pubitemid 40523737)
8. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Geneve
9. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2492.
10. Alberti KG, Zimmet PZ, Shaw J.E. The metabolic syndrome: a new world-wide definition from the International Diabetes Federation consensus. Lancet 2005; 366:1059-1062.
11. Sung KC, Kim BJ, Kim BS, Lee WY, Park JB,Wilson A.M. A comparison of the prevalence of the MS and its complications using three proposed definitions in Korean subjects. Am J Cardiol 2009; 103:1732-1735.
12. Luksiene DI, Baceviciene M, Tamosiunas A, Cerniauskiene LR, Margeviciene L, Reklaitiene R. Prevalence of the metabolic syndrome diagnosed using three different definitions and risk of ischemic heart disease among Kaunas adult population. Medicina (Kaunas) 2010; 46:61-69.
13. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of non-alcoholic fatty liver disease. Ann Intern Med 2005; 143:722-728.
14. Musso G, Gambino R, Bo S, Uberti B, Biroli G, Pagano G, Cassader M. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with ATP III criteria in nonobese nondiabetic subjects. Diabetes Care 2008; 31:562-568.
15. Gholam PM, Flancbaum I, Machan JT, Charney DA, Kotler D.P. Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol 2007; 102:399-408. (Pubitemid 46160554)
16. Hamaguchi M, Kokima T, Takeda N, Nagata C, Takeda J, Sarui H, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterology 2007; 13:1579-1584. (Pubitemid 46672668)
17. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37:917-923. (Pubitemid 36397405)
18. Bugianesi E, McCullough A, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005; 42:987-1000. (Pubitemid 43112663)
19. Ryan MC, Fenster Farin HM, Abbasi F, Reaven G.M. Comparison of waist circumference versus body mass index in diagnosing metabolic syndrome and identifying apparently healthy subjects at increased risk of cardiovascular disease. Am J Cardiol 2008; 102:40-46.
20. Jiang J, Torok N. Nonalcoholic steatohepatitis and the metabolic syndrome. Metab Syndr Relat Disord 2008; 6:1-8.
21. Joseph AE, Saverymuttu SH, Al-Sam S, Cook MG, Maxwell J.D. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43:26-31.